Tags

Type your tag names separated by a space and hit enter

Long term storage studies with a new stabilised formulation of yellow fever virus vaccine.
Dev Biol Stand. 1976 Oct; 36:279-83.DB

Abstract

A new formulation of yellow fever virus vaccine incorporating a stabiliser has been prepared which is very much more stable than conventional unstabilised vaccines. This vaccine has a half life of 2-4 years at 4 degrees C, 9 months at 20 degrees C and 10 days at 37 degrees C. Its greater stability should have considerable advantages, especially when it is used in tropical countries.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

1030425

Citation

Finter, N B., et al. "Long Term Storage Studies With a New Stabilised Formulation of Yellow Fever Virus Vaccine." Developments in Biological Standardization, vol. 36, 1976, pp. 279-83.
Finter NB, Burfoot C, Young PA, et al. Long term storage studies with a new stabilised formulation of yellow fever virus vaccine. Dev Biol Stand. 1976;36:279-83.
Finter, N. B., Burfoot, C., Young, P. A., & Ferris, R. (1976). Long term storage studies with a new stabilised formulation of yellow fever virus vaccine. Developments in Biological Standardization, 36, 279-83.
Finter NB, et al. Long Term Storage Studies With a New Stabilised Formulation of Yellow Fever Virus Vaccine. Dev Biol Stand. 1976;36:279-83. PubMed PMID: 1030425.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long term storage studies with a new stabilised formulation of yellow fever virus vaccine. AU - Finter,N B, AU - Burfoot,C, AU - Young,P A, AU - Ferris,R, PY - 1976/10/1/pubmed PY - 1976/10/1/medline PY - 1976/10/1/entrez SP - 279 EP - 83 JF - Developments in biological standardization JO - Dev. Biol. Stand. VL - 36 N2 - A new formulation of yellow fever virus vaccine incorporating a stabiliser has been prepared which is very much more stable than conventional unstabilised vaccines. This vaccine has a half life of 2-4 years at 4 degrees C, 9 months at 20 degrees C and 10 days at 37 degrees C. Its greater stability should have considerable advantages, especially when it is used in tropical countries. SN - 0301-5149 UR - https://www.unboundmedicine.com/medline/citation/1030425/Long_term_storage_studies_with_a_new_stabilised_formulation_of_yellow_fever_virus_vaccine_ L2 - https://www.lens.org/lens/search?q=citation_id:1030425 DB - PRIME DP - Unbound Medicine ER -